| Assessment of structural and functional similarity of biosimilar products: rituximab as a case study N Nupur, N Chhabra, R Dash, AS Rathore MAbs 10 (1), 143-158, 2018 | 54 | 2018 |
| Impact of mAb aggregation on its biological activity: rituximab as a case study R Bansal, R Dash, AS Rathore Journal of Pharmaceutical Sciences 109 (9), 2684-2698, 2020 | 30 | 2020 |
| Structure-based design of small peptide ligands to inhibit early-stage protein aggregation nucleation A Mishra, R Bansal, S Sreenivasan, R Dash, S Joshi, R Singh, ... Journal of Chemical Information and Modeling 60 (6), 3304-3314, 2020 | 12 | 2020 |
| A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus S Kiruthika, R Bhat, R Dash, AS Rathore, V Perumal, B Jayaram Scientific reports 11, 11723, 2021 | 8 | 2021 |
| Freeze thaw and lyophilization induced alteration in mAb therapeutics: Trastuzumab as a case study R Dash, AS Rathore Journal of Pharmaceutical and Biomedical Analysis 201, 114122, 2021 | 7 | 2021 |
| Assessment of Functional Characterization and Comparability of Biotherapeutics: a Review R Dash, SK Singh, N Chirmule, AS Rathore The AAPS Journal 24 (15), 2021 | 5 | 2021 |
| Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars AS Rathore, R Dash Biopharm International 33 (3), 34-39, 2019 | 2 | 2019 |
| Complement receptor 2 (CR2/CD21) R Dash, N Das Int. J. Res. Med. Sci 5, 1156-1160, 2017 | 2 | 2017 |
| Expression and modulation of complement receptor 2 (CR2/CD21) in the pathophysiology of rheumatoid arthritis R Dash, U Kumar, M Kanjilal, N Das International Journal of Research in Medical Sciences 4 (8), 3394, 2016 | 2 | 2016 |
| Study on awareness regardin g gender based violence among group D workers in public hospitals of Delhi, India: a gender perspective MM Singh, S Garg, R Dash, R Kumar, N Jain, N Sharma, T Anand International Journal of Community Medicine and Public Health 3 (6), 1510, 2016 | 2 | 2016 |
| An efficient computational protocol for template‐based design of peptides that inhibit interactions involving SARS‐CoV‐2 proteins A Chenna, WH Khan, R Dash, S Saraswat, A Chugh, AS Rathore, G Goel Proteins: Structure, Function, and Bioinformatics 91 (9), 1222-1234, 2023 | 1 | 2023 |
| Late-Stage Failures of Monoclonal Antibodies AS Rathore, R Dash | 1 | 2022 |
| Template-based design of peptides to inhibit SARS-CoV-2 RNA-dependent RNA polymerase complexation A Chenna, WH Khan, R Dash, AS Rathore, G Goel bioRxiv, 2022.01. 24.477502, 2022 | 1 | 2022 |
| Strengthening role of health sectors in gender based violence R Dash, MM Singh Int J Community Med Public Heal 3 (6), 1341-7, 2016 | 1 | 2016 |
| Current status and future prospective of breast cancer immunotherapy AS Rathore, N Chirmule, R Dash, A Chowdhury Academic Press, 2024 | | 2024 |
| Mathematical Modeling of Cell-based Potency Data for mAb Biotherapeutics R Dash, S Mandal, AS Rathore BioPharm International, 2022 | | 2022 |
| Template-based design of peptides to inhibit SARS-CoV-2 RNA-dependent RNA polymerase complexation (preprint) A Chenna, W Khan, R Dash, A Rathore, G Goel | | 2022 |
| Late-Stage Failures of Monoclonal Antibody Biotherapeutics AS Rathore, R Dash Biopharm International, 2021 | | 2021 |
| Emergence of India as a Global Manufacturing Hub for Biosimilars AS Rathore, S Joshi, R Dash, N Nupur, S Shravan BioPharm International 34 (11), 42-44, 2021 | | 2021 |
| Tools for Functional Assessment of Biotherapeutics AS Rathore, R Dash, R Jain, J Auclair LC GC North America 39 (6), 28, 2021 | | 2021 |
Anurag RathoreIndian Institute of Technology DelhiE-mail megerősítve itt: biotechcmz.com
